Moderna Inc (MRNA) USD0.0001
- Add to watchlist
- This stock can be held in a
Share news, reports & tips
-
Moderna shares slide as it slashes revenue forecast
13 January 2025 13:25
(Sharecast News) - Moderna slashed its 2025 revenue projection by $1bn on Monday, citing reduced demand for its Covid-19 and respiratory syncytial virus (RSV) vaccines.
-
Moderna numbers beat expectations, shares jump
7 November 2024 13:15
(Sharecast News) - Shares in Moderna rallied on Thursday after third-quarter revenues at the US biotech, best known for its Covid-19 vaccine, smashed expectations.
-
Moderna to slash R&D budget, shares fall
12 September 2024 12:41
(Sharecast News) - Shares in Moderna tumbled 11% in pre-market trading on Thursday, after the US biotech detailed plans to cut its research budget by more than $1bn.
-
Moderna lowers guidance after fall in quarterly revenue
1 August 2024 12:06
(Sharecast News) - Moderna reported a significant fall in second quarter revenue on Thursday, to $241m, down from $344m in the same period last year, as it lowered its full-year guidance amid weak Europe...
-
European drugs body backs Moderna jab
28 June 2024 12:34
(Sharecast News) - Europe's drug regulator has backed Moderna's novel vaccine for respiratory syncytial virus, the US pharmaceutical firm announced on Friday.
-
Moderna bets big on RSV vaccine as full-year guidance unchanged
2 May 2024 11:54
(Sharecast News) - Moderna saw its share price surge on Thursday after posting a smaller-than-expected quarterly loss as the Covid vaccine maker sets its sights on regulatory approvals of its second product...
-
US close: Stocks rise amid Nvidia-led tech rally
22 February 2024 22:23
(Sharecast News) - Wall Street saw a surge in stock performances on Thursday, buoyed by robust earnings reports from chipmaker Nvidia and positive data trends.
-
Moderna posts surprise profit, shares spark
22 February 2024 11:49
(Sharecast News) - Moderna posted a surprise quarterly profit on Thursday, despite sales of its Covid vaccine continuing to slide.
-
Moderna shares surge on cancer trial combo with Merck treatment
14 December 2023 12:13
(Sharecast News) - Shares in Moderna surged on Thursday after trial results of its experimental cancer vaccine, used in conjunction with Merck's Keytruda treatment, reduced the risk of death or relapse...
-
US close: Stocks rise as Dow snaps three-day losing streak
4 October 2023 23:00
(Sharecast News) - Wall Street ended with a rebound on Wednesday, with major US stock indices ending the day in positive territory following a streak of losses, triggered partially by alleviating bond yields...
-
Updated Covid vaccine effective against new strain - Moderna
6 September 2023 13:24
(Sharecast News) - Moderna's updated Covid-19 vaccine has shown to be effective against a potentially dangerous new variant, the US biotech said on Wednesday.
-
Moderna posts surprise first-quarter profit
4 May 2023 12:45
(Sharecast News) - Moderna reported above-forecast first-quarter numbers on Thursday, despite demand for its Covid-19 vaccine continuing to wane.
Company announcements Announcements
No company announcements about Moderna Inc USD0.0001 were found.
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.